Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

University of Toronto

$234,000.00

Wireless neurophotonic probes for the interrogation of neurons in memory circuits

EF 2018-19

Résumé
As the average age of the population of Canada and the developed world rises,*neurodegenerative conditions will become increasingly prevalent and a growing burden on*the healthcare system and economy. A major neurodegenerative disease is Alzheimers*disease (AD), which causes memory and cognition loss. AD and dementia affect roughly 1.1*million Canadians and incur an economic cost of $10.4B per year in Canada. Currently, there*is no cure or effective treatment. The Lancet Neurology Commission recently stated, an*effective therapy for AD is perhaps the greatest unmet need facing modern medicine.""*This project addresses the challenge of understanding neuron circuits in the brain involved in*memory, with the goal of improving the efficacy of neurostimulation therapies for AD and*dementia. Such treatments would stimulate specific brain circuits to promote memory*encoding and/or retrieval in patients with AD or dementia. The project will create a new type*of wireless, implantable deep brain probes for rodent experiments on memory loss rescue*that uses optical stimulation and electrical stimulation+recording of specific groups of*neurons. Importantly, these brain probes will be made using the same processes and*infrastructure as semiconductor microelectronics to ensure compatibility with volume*manufacturing and a viable technology translation path that will widely benefit neuroscientists*and clinical researchers.*This project brings together world-class expertise from around the globe in photonics,*electronics, neuroscience, and deep brain stimulation. In addition to the Canadian team*members, the project involves collaborators in France and United States who will provide*complementary expertise in the design, fabrication, and testing of the neural probes. The*results of this international project will benefit the health of Canadians and lead to high-value*neurotechnology products that are designed and integrated in Canada.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
508406-2017
Name nom
Poon, Joyce
Department département
Electrical & Computer Engineering, Edward S. Rogers Sr. Department of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2017
Award amount
234000
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2
Nb partie
3
Application title
Wireless neurophotonic probes for the interrogation of neurons in memory circuits
Keyword
NSERC
Application summary
As the average age of the population of Canada and the developed world rises,*neurodegenerative conditions will become increasingly prevalent and a growing burden on*the healthcare system and economy. A major neurodegenerative disease is Alzheimers*disease (AD), which causes memory and cognition loss. AD and dementia affect roughly 1.1*million Canadians and incur an economic cost of $10.4B per year in Canada. Currently, there*is no cure or effective treatment. The Lancet Neurology Commission recently stated, an*effective therapy for AD is perhaps the greatest unmet need facing modern medicine.""*This project addresses the challenge of understanding neuron circuits in the brain involved in*memory, with the goal of improving the efficacy of neurostimulation therapies for AD and*dementia. Such treatments would stimulate specific brain circuits to promote memory*encoding and/or retrieval in patients with AD or dementia. The project will create a new type*of wireless, implantable deep brain probes for rodent experiments on memory loss rescue*that uses optical stimulation and electrical stimulation+recording of specific groups of*neurons. Importantly, these brain probes will be made using the same processes and*infrastructure as semiconductor microelectronics to ensure compatibility with volume*manufacturing and a viable technology translation path that will widely benefit neuroscientists*and clinical researchers.*This project brings together world-class expertise from around the globe in photonics,*electronics, neuroscience, and deep brain stimulation. In addition to the Canadian team*members, the project involves collaborators in France and United States who will provide*complementary expertise in the design, fabrication, and testing of the neural probes. The*results of this international project will benefit the health of Canadians and lead to high-value*neurotechnology products that are designed and integrated in Canada.